Press Releases

  • VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics

  • VolitionRx Limited Releases Video Featuring Interviews with its Scientific Advisory Board

  • VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update

  • Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer

  • VolitionRx Limited Announces Completion of Sample Collection in Endometriosis Study

  • VolitionRx Announces $9 Million Private Placement

  • VolitionRx Limited Schedules Second Quarter 2018 Earnings Conference Call and Business Update

  • VolitionRx's First Research Use Only Product Is "On-The-Shelf" Today

  • Volition Extends Global Reach of its Clinical Trial Program

  • Volition Secures Additional $700,000 Non-Dilutive Funding from the Walloon Region